1 / 40

TUMOURS OF BLOOD ( HAEMOBLASTOSIS )

TUMOURS OF BLOOD ( HAEMOBLASTOSIS ) . Assistant-prof. V.Voloshyn . According: prof. Bodnar Ya.Ya.; prof. Sorokina I.V.; Frank Netter. 1.

guenevere
Télécharger la présentation

TUMOURS OF BLOOD ( HAEMOBLASTOSIS )

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TUMOURS OF BLOOD ( HAEMOBLASTOSIS ) Assistant-prof. V.Voloshyn According: prof. Bodnar Ya.Ya.; prof. Sorokina I.V.; Frank Netter 1

  2. Haemoblastoses - there are the tumours of lymphoid and myeloid tissueHaemoblastoses include leucosis and lymphadenomasLeucosis (leukaemia)There is the system tumour disease of haemopoetic tissue with the obligatory defeat of red marrow and supplanting (substitution) of normal blood shoot.Lymphadenomas– regional tumours of haemopoetic and/or lymphoid tissue. 2

  3. Epidemiology. Hemoblastoses take 5 seat among all tumours of peoples. The 30% of all Haemoblastoses are formed by children to 5 years age. Etiology. According to modern opinion leucosis arise up on mutational genetic basis. The question is about the specific mutations of haemopoetic cells, which lead to genes superactivating, that in a norm is responsible for their proliferation and differentiation. These genes obtained the name "prooncogenes” or cellular oncogenes, and is inalienable part of cellular genome, but at the same time have the hidden blastomogenic potencies. Surplus expression of them causes degeneration of marrow cells in leukemic. 3

  4. Classification: I) Leucosis 4

  5. Diagram of haemopoesis 5

  6. Classification: (continuation I) II) Lymphomas — regional tumors: • lympho sarcoma: lymphocyte, prolymphocyte, lymphoblast, immunoblast, lymphoplasmocyte, African lymphoma (Burkitt's); • mycosis fungoides; • Sezary's disease; • reticulosarcoma; • lymphogranulomatosis (Hodgkin's disease). 6

  7. Classification: (continuation III) • leukemic (tens and hundreds thousand leukosis cells per 1 microl); • subleukemic (not more that 15.000 — 25.000 per 1 microl); • leukopenic (leukocyte count is reduced but leukosis cells can be found); • aleukemic (leukosiscells in the blood are absent). 7

  8. PATHOMORPHOLOGICAL SYNDROMES: • Pyoid bone marrow due to proliferation of the tumor cells (mature or immature, respectively) in the bone marrow with displacement of the red sprout. Macroscopically, bone marrow is grayish-whitish. • Leukoses infiltration of hemopoietic organs (bone marrow, spleen, lymphatic glands) at first, then of the other organs (mucous membranes, myocardium, kidneys, brain, etc., vessels). • The displacement of the red sprout of the bone marrow causes anemia. • Severe hemorrhagic syndrome in combination with anemia and destruction of the vascular walls with leukoses infiltration develop as a manifestation of thrombocytes formation in the bone marrow. • Necrotic tonsillitis, gingivitis develop due to leukoses infiltration of the oral mucosa and tonsils against the background of immunogenesis inhibition. • Secondary infection often accompanies the process, sepsis may develop. • Foci of extramedullary hemopoiesis develop in the liver, spleen, kidneys, lymphatic glands as compensatory adaptation reaction directed to restoration of the red sprout. 8

  9. The acute undifferentiated leucosis • Leukemic infiltration of marrow, spleen, lymphonoduses, lymphoid follicles, vessels walls. • Necrotizing quinsy. • Hemorragic syndrome 9

  10. CLASSIFICATION IN SUBTYPES OF ACUTE MYELOPROLIFERATIVE DISEASES 10

  11. Acute myeloblastic leucosis • Leukemic infiltration by the blastic cells of marrow, spleen, liver, kidneys, rarer lymphatic nodes. • Infiltration of mucuses and serosal membranes by the blastic cells: leukemic meningitis, leukemic pneumonitis, leukemic gastritis. • Hemorragic diathesis, bleeding, ulcerous-necrotic complications, sepsis. 11

  12. Acute myelogenous leukemia Leukemic infiltration of kidneys, Leukemic infiltration in bone marrow and spleen Skin infiltration 12

  13. Acute Myelogenous Leukemia • Bone marrow biopsy specimen acute myelogenous leukemia (AML-M1). Diffuse immature myeloid hyperplasia with early maturation (chlorocetate esterase Stain; red cells = myeloid differentiation; AML-MO would show similar picture without red cells) Blood smear of acute myelogenous leukemia (AML-M1) Immature myeloblasts, partly with lymphoid appearance 13

  14. Lymphoblastic leucosis • Lymphoblasts infiltration of marrow, lymphatic nodes, thymus gland, spleen, intestine, kidneys • Thymomegaly • Spleenomegaly 14

  15. Acute megakaryoblastic leukemia 15

  16. Acute erythroblastic leukemia Acute erythroblastic leukemia (AML-M6). Blood smear with immature erythroblastic cells (arrows) 16

  17. Complications and causes of death • hemorrhage to vital organs (brain); • ulcerative necrotic and septic complications (sepsis). 17

  18. DISTINCTIVE FEATURES OF ACUTE AND CHRONIC LEUKAEMIAS • Bone marrow and blood picture (In acute leukoses the blasts are observed, in chronic leukoses the mature cells are found). • Leukemic failure (hiatus leucemicus) characterizes acute leukoses. It is sharp increase of blast count and single mature elements while transitional forms are absent. • Sharp enlargement of the spleen, liver, kidneys and lymphatic glands characterizes chronic leukoses while in chronic leukoses it is less marked. The spleen can weigh 6—8 kg, the liver 5—6 kg. 18

  19. 19

  20. Chronic myelosis • Blastic crises • Pyoid marrow. • Gray-red blood. • Hepatomegalia. • Spleenomegaly • Myelocytes infiltration of lymphoid organs. 20

  21. Chronic Myelogenous Leukemia Blood smear. Showing increased number of metamyelocytes and myelocytes (arrow) Blood marrow smear. Mild increase in myelocytes and myeloblasts and decreased erythropoiesis (arrows) 21

  22. Chronic Myelogenous Leukemia a)Myelomonocytic variant of chronic myelogenous leukemia (CMoML). Immature monocytoid cells (arrow) b) Bone marrow smear of CMoML. Increased number of monocytoid cells (neutral anaphthyl esterase reaction for monocytes): brown cells (arrow) 22

  23. Chronic lympholeucosis • Leukemic infiltrates takes place in marrow, lymphatic nodes, spleen and liver • Blastic crises are possible • Marrow is red • Spleenomegaly • A liver and kidneys are increased • Hemorrhages • Pneumonias 23

  24. Paraproteinaemic leucosis. Myeloma (1.2.b.2.a) 24

  25. 25

  26. 26

  27. myelomas (chronic, lymphocyte, paraproteinemic group) • plasmocyte, • plasmoblast, • polymorphocellular, • small-cell. Morphological forms: 1) diffuse, 2) diffuse nodular, 3) multiple nodular. 27

  28. Lymphadenomas • Regional tumours diseases of haemopoetic and lymphatic tissue. • Lymphomas include lymphosarcoma, Sezary's illness, Hodgkin's illness 28

  29. Lymphosarcoma 29

  30. non-Hodgkin lymphoma (NHL). • Lymphoplasmacytoid non-Hodgkin lymphoma (NHL). Showing a mixture of lymphocytes, plasmacytoid cells and occasional immunoblast (arrow; Giemsa stain) • Follicular non-Hodgkin lymphoma (FCC) (follicular center cell lymphoma). Showing nodular, partly follicular, structure with a mixed small and large cell population (Giemsa stain) 30

  31. non-Hodgkin lymphoma • Follicular center cell lymphoma. With predominant large cells. The follicular may be still discernable or completely lost (H& E stain) • Large cell immunoblastic non-Hodgkin lymphoma. Showing predominance of immunoblasts (arrow) with some plasmacytoid features (PAS stain) 31

  32. Non-Hodgkin lymphoma • Burkitt-type non-Hodgkin lymphoma (here classical Burkitt lymphoma). Showing densely packed lymphoblasts with scattered histiocytes containing nuclear debris (starry sky pattern; arrow) Infiltration of maxilla (Burkitt) 32

  33. Non-Hodgkin lymphoma Infiltration of femur marrow (immunoblastic) 33

  34. Non-Hodgkin lymphoma Non-Hodgkin lymphoma. Infiltration of stomach (immunoblastic). Non-Hodgkin lymphoma. Infiltration of spleen (follicular) Non-Hodgkin Lymphomas, Gross View 34

  35. HODGKIN'S DISEASE(HD) CLINICO-MORPHOLOGICAL CLASSIFICATION variant 1: with prevail of lymphoid tissue (lymphohistiocyte); variant 2: nodular sclerosis variant 3: mixed-cell; variant 4: with inhibition of lymphoid tissue. 35

  36. Lymphogranulomatosis (Hodgkin's) 36

  37. HD HODGKIN'S DISEASE HODGKIN'S DISEASE Gross infiltration of spleen in Hodgkin disease (HD) Gross infiltration of spine in Hodgkin disease (HD) 37

  38. HD HODGKIN'S DISEASE HODGKIN'S DISEASE Lymphocyte-predominant type of Hodgkin disease. With only occasional Hodgkin and Reed-Sternberg cells (arrows)(HD) Mixed cellularity type of Hodgkin disease. With mixed population of lymphocytes, histiocytes (which may show epithelioid features), eosinophils, Hodgkin and Reed-Sternberg cells (arrows) 38

  39. HD Lymphocyte-depleted type of Hodgkin disease. Showing predominance of atypical histiocytoblasts with many Hodgkin and Reed-Sternberg cells (arrows) Nodular sclerosis type (C1) of Hodgkin disease. With paracortical atrophy, fibrosis, and typical lacunar-type Hodgkin and Reed-Sternberg cells (arrow) 39

  40. Thank you for attention! 40

More Related